Stock Price
5.93
Daily Change
-0.05 -0.75%
Monthly
-3.97%
Yearly
36.84%
Q2 Forecast
5.76

Ardelyx reported $207.61M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Amgen USD 54.59B 1.62B Sep/2025
Ardelyx USD 207.61M 968K Sep/2025
aTyr Pharma USD 1.84M 8K Sep/2025
Corcept Therapeutics USD 6.36M 247K Sep/2025
Curis USD 0 0 Jun/2022
Sanofi EUR 21.76B 530M Sep/2025
TG Therapeutics USD 245.34M 8.38M Sep/2025
United Therapeutics USD 200M 100M Mar/2025
Xoma USD 120.79M 3.27M Jun/2024